Issuer directory · Biotechnology · page 3
Biotechnology: issuers 201 to 300 of 832.
Ranked by the amount reported sold on the newest Form D. Page 1 holds the largest raises in the group.
| Issuer | Reported sold | Investors | Exemption | Newest notice | Filings | Platform |
|---|---|---|---|---|---|---|
| Arda Therapeutics, Inc. | $43.3M | 17 | 506(b) | Oct 2, 2024 | 1 | direct |
| Arrivo BioVentures, LLC | $43.2M | 58 | 506(b) | Nov 29, 2023 | 1 | direct |
| NextPoint Therapeutics, Inc. | $42.5M | 15 | 506(b) | Feb 14, 2024 | 1 | direct |
| TRex Holdings Inc. | $42.3M | 13 | 506(b) | Nov 26, 2024 | 1 | direct |
| Evida Biosciences Inc. | $42.0M | 26 | 506(b) | Oct 11, 2024 | 1 | direct |
| Promaxo, Inc. | $41.9M | 163 | 506(b) | Jul 10, 2024 | 2 | direct |
| Pi Health Inc. | $41.8M | 1 | 506(b) | Mar 14, 2024 | 1 | direct |
| ShiraTronics, Inc | $41.7M | 11 | 506(b) | Aug 11, 2023 | 3 | direct |
| Vernal Biosciences, Inc. | $41.0M | 10 | 506(b) | Jun 16, 2023 | 2 | direct |
| Skylark Bio, Inc. | $40.9M | 2 | 506(b) | Apr 19, 2024 | 3 | direct |
| Terremoto Biosciences, Inc. | $40.7M | 14 | 506(b) | Apr 22, 2026 | 1 | direct |
| Estuary Biotherapeutics, Inc. | $40.7M | 25 | 506(b) | Oct 16, 2026 | 1 | direct |
| Trailhead Biosystems Inc. | $40.6M | 7 | 506(b) | Jul 30, 2026 | 5 | direct |
| Entact Bio, Inc. | $40.3M | 7 | 506(b) | May 15, 2024 | 2 | direct |
| IntraBio Inc. | $40.3M | 37 | 506(b) | Mar 25, 2024 | 1 | direct |
| Relation Therapeutics Inc. | $40.3M | 10 | 506(b) | Jan 19, 2024 | 1 | direct |
| ENCOMPASS TECHNOLOGIES, INC. | $40.3M | 5 | 506(b) | May 19, 2025 | 1 | direct |
| Prana Therapies, Inc. | $40.2M | 9 | 506(b) | Aug 10, 2026 | 1 | direct |
| Benitec Biopharma Inc. | $40.0M | 17 | 506(b) | Apr 25, 2024 | 1 | direct |
| SeLux Diagnostics, Inc. | $40.0M | 9 | 506(b) | Feb 13, 2024 | 1 | direct |
| OrsoBio, Inc. | $40.0M | 7 | 506(b) | Aug 28, 2024 | 1 | direct |
| Antares Therapeutics, Inc. | $40.0M | 3 | 506(b) | Mar 12, 2025 | 1 | direct |
| Firefly Bio, Inc. | $40.0M | 8 | 506(b) | Mar 26, 2024 | 1 | direct |
| Noetik Inc. | $40.0M | 20 | 506(b) | Aug 13, 2024 | 1 | direct |
| VITARA BIOMEDICAL, INC. | $40.0M | 9 | 506(b) | Dec 6, 2023 | 4 | direct |
| Graviton BioScience Corp | $39.8M | 11 | 506(b) | Dec 4, 2023 | 1 | direct |
| MarvelBiome, Inc. | $39.6M | 10 | 506(b) | Oct 22, 2025 | 1 | direct |
| Transition Bio, Inc. | $39.1M | 22 | 506(b) | Mar 7, 2023 | 2 | direct |
| Antiva Biosciences, Inc. | $38.5M | 21 | 506(b) | Oct 11, 2024 | 2 | direct |
| Auron Therapeutics, Inc. | $38.4M | 10 | 506(b) | Oct 20, 2023 | 2 | direct |
| Memento Medicines, Inc. | $38.0M | 7 | 506(b) | Jun 16, 2026 | 1 | direct |
| ChromaCode, Inc. | $38.0M | 16 | 506(b) | Feb 27, 2023 | 2 | direct |
| Senti Biosciences, Inc. | $37.6M | 15 | 506(b) | Dec 19, 2024 | 1 | direct |
| Crossbow Therapeutics, Inc. | $37.6M | 15 | 506(b) | Apr 12, 2023 | 1 | direct |
| DiaMedica Therapeutics Inc. | $37.5M | 34 | 506(b) | Jun 27, 2023 | 1 | direct |
| Normunity Holding Company, LLC | $37.5M | 13 | 506(b) | Jan 14, 2025 | 1 | direct |
| Caldera Therapeutics, Inc. | $37.5M | 3 | 506(b) | Jan 21, 2026 | 1 | direct |
| Noveome Biotherapeutics, Inc. | $36.2M | 66 | 506(b) | Aug 8, 2024 | 2 | direct |
| Theradaptive, Inc. | $36.2M | 65 | 506(b) | Aug 4, 2026 | 1 | direct |
| PTC THERAPEUTICS, INC. | $35.9M | 40 | 506(b) | May 8, 2023 | 1 | direct |
| ECM Therapeutics, Inc. | $35.2M | 190 | 506(b) | Oct 10, 2025 | 8 | direct |
| Virtual Incision Corp | $35.1M | 60 | 506(b) | Oct 5, 2026 | 1 | direct |
| PolyPid Ltd. | $35.0M | 20 | 506(b) | Jan 22, 2024 | 1 | direct |
| Kate Therapeutics Inc. | $35.0M | 5 | 506(b) | Aug 7, 2024 | 1 | direct |
| Kolon TissueGene, Inc. | $35.0M | 1 | 506(b) | Jun 5, 2024 | 1 | direct |
| RHF IV Holding Company, LLC | $34.9M | 125 | 506(b) | Jan 17, 2024 | 1 | direct |
| Consano Bio, Inc. | $34.8M | 28 | 506(b) | Mar 20, 2026 | 1 | direct |
| Instylla, Inc. | $34.8M | 29 | 506(b) | Jul 28, 2026 | 2 | direct |
| Iantrek, Inc. | $34.7M | 21 | 506(b) | Aug 21, 2025 | 1 | direct |
| Centerline Biomedical, Inc. | $34.7M | 22 | 506(b) | Nov 3, 2023 | 1 | direct |
| BRIGHT MINDS BIOSCIENCES INC. | $34.6M | 13 | 506(b) | Nov 19, 2024 | 1 | direct |
| Delfi Diagnostics, Inc. | $34.3M | 50 | 506(b) | Dec 18, 2025 | 1 | direct |
| Radiant Biotherapeutics Inc. | $34.3M | 7 | 506(b) | Oct 1, 2024 | 1 | direct |
| AXOFT, INC. | $34.2M | 13 | 506(b) | May 7, 2026 | 1 | direct |
| G.I. Windows, Inc. | $34.1M | 29 | 506(b) | Oct 9, 2024 | 1 | direct |
| Satellos Bioscience Inc. | $33.3M | 16 | 506(b) | May 25, 2023 | 1 | direct |
| Glyphic Biotechnologies, Inc. | $33.2M | 37 | 506(b) | Feb 16, 2024 | 1 | direct |
| Nectero Medical Inc | $32.8M | 30 | 506(b) | May 10, 2024 | 1 | direct |
| Manifold Biotechnologies, Inc. | $32.8M | 10 | 506(b) | Dec 3, 2024 | 1 | direct |
| DermBiont, Inc. | $32.7M | 72 | 506(b) | Nov 13, 2024 | 3 | direct |
| Dualitas Therapeutics, Inc. | $32.6M | 7 | 506(b) | Nov 18, 2025 | 1 | direct |
| SURGE Therapeutics, Inc. | $32.0M | 22 | 506(b) | Jun 2, 2023 | 1 | direct |
| Human Longevity, Inc. | $32.0M | 18 | 506(b) | Aug 21, 2024 | 2 | direct |
| OrthoBio Therapeutics, Inc. | $31.4M | 45 | 506(b) | Jul 2, 2025 | 1 | direct |
| Atommap Corp | $31.1M | 29 | 506(b) | Mar 20, 2026 | 1 | direct |
| Bright Uro, Inc. | $31.0M | 108 | 506(b) | Jul 3, 2025 | 4 | direct |
| Ventaris Surgical, Inc. | $30.7M | 57 | 506(b) | Mar 2, 2026 | 1 | direct |
| Hinge Bio, Inc. | $30.6M | 82 | 506(b) | Jan 15, 2025 | 1 | direct |
| Myrtelle Inc. | $30.5M | 21 | 506(b) | Dec 23, 2025 | 1 | direct |
| MiNDERA Corp | $30.4M | 25 | 506(b) | Jul 28, 2026 | 1 | direct |
| Alloy Therapeutics, Inc. | $30.0M | 11 | 506(b) | Apr 15, 2026 | 1 | direct |
| FEMASYS INC | $30.0M | 41 | 506(b) | Aug 20, 2026 | 1 | direct |
| RYNE Biotechnology Inc. | $30.0M | 9 | 506(b) | Mar 1, 2024 | 1 | direct |
| Brenig Therapeutics, Inc. | $30.0M | 6 | 506(b) | Jul 30, 2024 | 1 | direct |
| Renasant Bio, Inc. | $30.0M | 4 | 506(b) | Jul 14, 2025 | 1 | direct |
| OmniAb, Inc. | $30.0M | 15 | 506(b) | Sep 10, 2025 | 1 | direct |
| ReAlta Life Sciences, Inc. | $29.9M | 149 | 506(b) | May 21, 2025 | 1 | direct |
| Nanopath Inc | $29.9M | 21 | 506(b) | Nov 13, 2026 | 1 | direct |
| Mythic Therapeutics, Inc. | $29.9M | 30 | 506(b) | Dec 26, 2024 | 1 | direct |
| Deka Biosciences, Inc. | $29.9M | 33 | 506(b) | Dec 8, 2023 | 1 | direct |
| VitriVax, Inc. | $29.4M | 83 | 506(b) | Nov 17, 2025 | 1 | direct |
| SYNDEVRX INC | $29.4M | 13 | 506(b) | Oct 10, 2024 | 1 | direct |
| Pinteon Therapeutics, Inc. | $29.2M | 2 | 506(b) | Nov 12, 2025 | 4 | direct |
| Convergent Therapeutics, Inc. | $29.2M | 15 | 506(b) | May 22, 2023 | 1 | direct |
| Clear Labs, Inc. | $29.1M | 33 | 506(b) | Dec 30, 2024 | 1 | direct |
| Cresilon, Inc. | $29.0M | 217 | 506(c) | Jun 26, 2026 | 2 | direct |
| NanoCellect Biomedical, Inc. | $28.9M | 32 | 506(b) | Jun 30, 2023 | 1 | direct |
| Vektor Medical, Inc. | $28.9M | 98 | 506(b) | Feb 20, 2024 | 1 | direct |
| Medcura, Inc. | $28.5M | 174 | 506(b) | Jul 25, 2025 | 1 | direct |
| Addition Therapeutics, Inc. | $28.0M | 9 | 506(b) | Dec 22, 2025 | 1 | direct |
| Allyx Therapeutics, Inc. | $27.9M | 33 | 506(b) | Oct 21, 2026 | 2 | direct |
| Delphinus Medical Technologies, Inc. | $27.6M | 8 | 506(b) | Apr 3, 2025 | 3 | direct |
| Clarametyx Biosciences, Inc. | $27.5M | 7 | 506(b) | Jan 19, 2024 | 1 | direct |
| SIRPant Immunotherapeutics, Inc. | $27.1M | 10 | 506(b) | Jan 22, 2024 | 3 | direct |
| Bonum Therapeutics, Inc. | $26.9M | 8 | 506(b) | Apr 17, 2026 | 1 | direct |
| Promaxo Holdings, Inc. | $26.8M | 118 | 506(b) | Mar 30, 2026 | 1 | direct |
| NEUROLUTIONS INC | $26.5M | 9 | 506(b) | Mar 17, 2025 | 1 | direct |
| Coya Therapeutics, Inc. | $26.5M | 122 | 506(b) | Dec 20, 2023 | 1 | direct |
| Rejoni, Inc. | $26.3M | 22 | 506(b) | Oct 18, 2023 | 3 | direct |
| View Point Medical, Inc. | $26.2M | 63 | 506(b) | Jun 7, 2023 | 6 | direct |
